Link Pharma Chem Ltd Balance Sheet: Consolidated Financial Analysis & Historical Data (15 Years)

Annual Results

Results Snapshot

Figures in Cr

Standalone - Balance Sheet Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Balance Sheet Analysis Highlights

Borrowings

YoY Growth in year ended Mar 2025 is -37.31% vs 5.25% in Mar 2024

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

Fixed Assets

YoY Growth in year ended Mar 2025 is -6.64% vs 10.44% in Mar 2024

Investments

YoY Growth in year ended Mar 2025 is -29.69% vs -19.51% in Mar 2024

Current Assets

YoY Growth in year ended Mar 2025 is -3.21% vs -34.30% in Mar 2024

Compare Balance Sheet Results of Link Pharma Chem

Select Peers

Figures in Cr

Standalone - Balance Sheet Results

Change(INR)

Change(%)

No of Months

EQUITY AND LIABILITIES

Share Capital

4.44

5.00

-0.56

-11.20%

Share Warrants & Outstandings

Total Reserve

8.22

2.71

5.51

203.32%

Shareholder's Funds

12.66

7.71

4.95

64.20%

Minority Interest

0.00

0.00%

Long-Term Borrowings

0.42

0.00

0.42

0.00%

Secured Loans

0.42

0.00

0.42

0.00%

Unsecured Loans

0.00

0.00%

Deferred Tax Assets / Liabilities

-0.23

0.32

-0.55

-171.88%

Other Long Term Liabilities

0.00

0.59

-0.59

-100.00%

Long Term Trade Payables

0.00

0.00%

Long Term Provisions

0.16

0.13

0.03

23.08%

Total Non-Current Liabilities

0.35

1.04

-0.69

-66.35%

Current Liabilities

Trade Payables

3.48

0.00

3.48

0.00%

Other Current Liabilities

0.74

0.13

0.61

469.23%

Short Term Borrowings

5.37

0.00

5.37

0.00%

Short Term Provisions

0.46

0.34

0.12

35.29%

Total Current Liabilities

10.05

0.47

9.58

2,038.30%

Total Liabilities

23.06

9.22

13.84

150.11%

ASSETS

Non-Current Assets

0.00

0.00%

Gross Block

15.95

2.04

13.91

681.86%

Less: Accumulated Depreciation

6.67

0.82

5.85

713.41%

Less : Impairment of Assets

0.00

0.00%

Net Block

9.28

1.22

8.06

660.66%

Lease Adjustment

0.00

0.00%

Capital Work in Progress

0.00

0.00%

Intangible assets under development

0.00

0.00%

Pre-operative Expenses pending

0.00

0.00%

Assets in transit

0.00

0.00%

Non Current Investments

2.06

0.59

1.47

249.15%

Long Term Loans & Advances

0.53

0.00

0.53

0.00%

Other Non Current Assets

0.04

0.00

0.04

0.00%

Total Non-Current Assets

11.90

1.81

10.09

557.46%

Current Assets Loans & Advances

Current Investments

0.00

0.01

-0.01

-100.00%

Inventories

5.74

0.12

5.62

4,683.33%

Sundry Debtors

5.02

0.02

5.00

25,000.00%

Cash and Bank

0.06

6.87

-6.81

-99.13%

Other Current Assets

0.06

0.09

-0.03

-33.33%

Short Term Loans and Advances

0.28

0.29

-0.01

-3.45%

Total Current Assets

11.16

7.41

3.75

50.61%

Net Current Assets (Including Current Investments)

1.11

6.93

-5.82

-83.98%

Total Current Assets Excluding Current Investments

11.16

7.40

3.76

50.81%

Miscellaneous Expenses not written off

0.00

0.00%

Total Assets

23.06

9.22

13.84

150.11%

Contingent Liabilities

0.11

0.00

0.11

0.00%

Total Debt

5.78

0.00

5.78

0.00%

Book Value per share (adjusted)

28.51

15.43

13.08

84.77%

Annual - Borrowings

Borrowings 5.78 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -37.31% vs 5.25% in Mar 2024

Annual - Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets

Fixed Assets 9.28 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -6.64% vs 10.44% in Mar 2024

Annual - Investments

Investments 2.06 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -29.69% vs -19.51% in Mar 2024

Annual - Current Assets

Current Assets 11.16 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -3.21% vs -34.30% in Mar 2024